The Latest Headlines at Zolmax


Beauty Health’s (SKIN) “Buy” Rating Reaffirmed at Canaccord Genuity Group
Canaccord Genuity Group restated their buy rating on shares of Beauty Health (NASDAQ:SKIN – Get Rating) in a research report report published on Tuesday morning, Benzinga reports. They currently have a $18.00 price objective... More of this article »
Rush Street Interactive (NYSE:RSI) Receives Market Outperform Rating from JMP Securities
JMP Securities restated their market outperform rating on shares of Rush Street Interactive (NYSE:RSI – Get Rating) in a research report released on Tuesday, Benzinga reports. They currently have a $8.00 price target on the... More of this article »
Citigroup Trims Sabra Health Care REIT (NASDAQ:SBRA) Target Price to $10.50
Sabra Health Care REIT (NASDAQ:SBRA – Get Rating) had its price objective lowered by Citigroup from $13.00 to $10.50 in a report published on Tuesday morning, Benzinga reports. Citigroup currently has a neutral rating on the... More of this article »
Lyft (NASDAQ:LYFT) Receives “Sector Perform” Rating from Royal Bank of Canada
Royal Bank of Canada reaffirmed their sector perform rating on shares of Lyft (NASDAQ:LYFT – Get Rating) in a research report report published on Tuesday morning, Benzinga reports. Royal Bank of Canada currently has a $11.00... More of this article »-logo.png?v=20211130090720&w=240&h=220&zc=2)
Roth Mkm Trims Real Good Food (NASDAQ:RGF) Target Price to $7.00
Real Good Food (NASDAQ:RGF – Get Rating) had its price target cut by Roth Mkm from $12.00 to $7.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have a buy rating on the stock. Separately,... More of this article »
JMP Securities Reiterates Market Outperform Rating for Incyte (NASDAQ:INCY)
JMP Securities reissued their market outperform rating on shares of Incyte (NASDAQ:INCY – Get Rating) in a report published on Tuesday, Benzinga reports. They currently have a $113.00 price objective on the biopharmaceutical... More of this article »
Generation Income Properties (NASDAQ:GIPR) Receives “Buy” Rating from EF Hutton Acquisition Co. I
EF Hutton Acquisition Co. I restated their buy rating on shares of Generation Income Properties (NASDAQ:GIPR – Get Rating) in a research note released on Tuesday, Benzinga reports. The firm currently has a $6.00 price objective... More of this article »
Gannett (NYSE:GCI) Price Target Cut to $1.70 by Analysts at Citigroup
Gannett (NYSE:GCI – Get Rating) had its target price lowered by Citigroup from $2.60 to $1.70 in a research note issued to investors on Tuesday morning, Benzinga reports. Citigroup currently has a sell rating on the stock. Separately,... More of this article »
Nutrien’s (NTR) Hold Rating Reaffirmed at Erste Group Bank
Erste Group Bank reiterated their hold rating on shares of Nutrien (NYSE:NTR – Get Rating) in a research note released on Tuesday morning, Benzinga reports. Several other equities research analysts have also weighed in on the... More of this article »
Cinemark (NYSE:CNK) Receives Buy Rating from Benchmark
Benchmark reaffirmed their buy rating on shares of Cinemark (NYSE:CNK – Get Rating) in a research report released on Tuesday morning, Benzinga reports. They currently have a $17.00 target price on the stock. A number of other... More of this article »
TELA Bio’s (TELA) “Buy” Rating Reiterated at Canaccord Genuity Group
Canaccord Genuity Group reiterated their buy rating on shares of TELA Bio (NASDAQ:TELA – Get Rating) in a research note issued to investors on Tuesday, Benzinga reports. The firm currently has a $15.00 price target on the stock. Separately,... More of this article »Erste Group Bank Reaffirms Hold Rating for Walmart (NYSE:WMT)
Erste Group Bank reissued their hold rating on shares of Walmart (NYSE:WMT – Get Rating) in a research note released on Tuesday, Benzinga reports. Several other equities research analysts have also issued reports on the stock.... More of this article »
IceCure Medical (NASDAQ:ICCM) Receives Buy Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of IceCure Medical (NASDAQ:ICCM – Get Rating) in a report published on Tuesday, Benzinga reports. They currently have a $3.00 price objective on the stock. IceCure Medical Stock... More of this article »